Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2018.Jan.17

FDA Clearance of IND Application for A Phase 1 Study of A Monoclonal Antibody Cancer Immunotherapy (OBI-888)

2018.Jan.08

Shilin District Court deny OBI's request to submit the case for trial

2018.Jan.05

OBI Pharma Inc. to attend the investor conference on new drug development, hosted by Masterlink Securities

2017.Dec.29

Capital increase for new shares to transfer to AP Biosciences, Inc.

2017.Dec.22

OBI Pharma Inc. to attend the 36th J.P. Morgan Annual Healthcare Conference

2017.Dec.05

OBI Pharma Inc. to attend Citi's 2017 Global Healthcare Conference

2017.Nov.28

OBI Pharma Inc. to attend the 2017 Asia Pacific Healthcare Forum, hosted by Goldman Sachs

2017.Nov.16

SFIPC and OBI jointly agreed to withdraw the proceedings on Civil case regarding the dismissal of the Chairman of the company.

2017.Oct.20

OBI Plans to Issue New Shares in Exchange for the AP Biosciences, Inc. Shares Owned by AbProtix,Inc, Subject to Regulatory Approval

2017.Oct.20

Announcement on Change of the Accounting Officer

News

Latest News

Events

Latest events